Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-04-07

Clinical Trial Update: Post-operative Corticosteroid Treatment After Mitral Valve Surgery [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating post-operative corticosteroid treatment after mitral valve surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kuopio University Hospital | Conditions: Atrial Fibrillation | Phase 2, Phase 3 | Status: WITHDRAWN